CG Oncology Inc. CGON 深 滬
等待開盤 08-14 09:30:00 美东时间
26.12
+1.170
+4.69%
華盛通- 最 高26.23
- 今 開25.20
- 成交量 32.29万股
- 最 低 25.14
- 昨 收 24.95
- 總市值 19.91亿
- 52周最高 40.47
- 市盈率 靜 --
- 換手率 0.42%
- 52周最低 14.80
- 委 比 18.21%
- 總股本 7622.53万
- 歷史最高 50.23
- 量 比 0.67
- 振 幅 4.37%
- 歷史最低 14.80
- 每 手 1
- 風險率 5.26%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多CG Oncology Q2 EPS $(0.54) Misses $(0.48) Estimate
CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.54) per share which missed the analyst consensus estimate of $(0.48) by 12.27 percent. This is a 92.86 percent decrease over losses of $(0.28) per share from the
08-08 21:43
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates
CG Oncology reported strong positive data from its Phase 3 BOND-003 trial for cretostimogene, showing high complete response rates and durability, with promising signals in additional cohorts. They initiated a new trial combining cretostimogene with gemcitabine and secured a favorable legal verdict eliminating future royalties to ANI Pharmaceuticals. Financially, the company has $661.1 million in cash, with increased R&D and G&A expenses leading ...
08-08 12:00
Delaware Court Gives Unanimous Verdict Detailing That CG Oncology Will Owe No Future Royalties Or Other Payments To ANI Pharmaceuticals
CG Oncology, Inc. (NASDAQ:CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today
07-30 04:24
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Medpace Hldgs (NASDAQ:MEDP) shares moved upwards by 44.6% to $446.6 du...
07-22 20:07
Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock
Across the recent three months, 7 analysts have shared their insights on CG Onc...
07-17 05:03
大摩力荐CG Oncology(CGON.US) 其膀胱癌疗法具有显著优势
摩根士丹利将制药公司CG Oncology(CGON.US)的目标价从52美元上调至56美元，同时维持“增持”评级。
07-07 14:24
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
Morgan Stanley Maintains Overweight on CG Oncology, Raises Price Target to $56
Morgan Stanley analyst Jeffrey Hung maintains CG Oncology (NASDAQ:CGON) with a Overweight and raises the price target from $52 to $56.
06-17 23:02
